Cargando…
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p
BACKGROUND: As a type of non-coding RNA, circular RNAs (circRNAs) are considered to be functional molecules associated with human cancers. An increasing number of circRNAs have been verified in malignant progression in a number of cancers. The circRNA, circFBXW7, has been proven to play an important...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044477/ https://www.ncbi.nlm.nih.gov/pubmed/33889522 http://dx.doi.org/10.21037/tlcr-21-230 |
_version_ | 1783678494263214080 |
---|---|
author | Dong, Yanting Qiu, Tong Xuan, Yunpeng Liu, Ao Sun, Xiao Huang, Zhangfeng Su, Wenhao Du, Wenxing Yun, Tianxiang Wo, Yang Navarro, Alfons Jiao, Wenjie |
author_facet | Dong, Yanting Qiu, Tong Xuan, Yunpeng Liu, Ao Sun, Xiao Huang, Zhangfeng Su, Wenhao Du, Wenxing Yun, Tianxiang Wo, Yang Navarro, Alfons Jiao, Wenjie |
author_sort | Dong, Yanting |
collection | PubMed |
description | BACKGROUND: As a type of non-coding RNA, circular RNAs (circRNAs) are considered to be functional molecules associated with human cancers. An increasing number of circRNAs have been verified in malignant progression in a number of cancers. The circRNA, circFBXW7, has been proven to play an important role in tumor proliferation and metastasis. However, whether circFBXW7 influences progression in lung adenocarcinoma (LUAD) remains unclear. METHODS: Quantitative real-time reverse transcriptase PCR (qRT-PCR) was used to verify circFBXW7 in LUAD cell lines and LUAD tissues. Kaplan-Meier analysis was then used to compare the disease-free survival (DFS) and overall survival (OS) of these LUAD patients. The biological function of circFBXW7 was examined by overexpression and knockdown of circFBXW7 using MTT assay, EdU assay, wound-healing assay, and Transwell in vitro assays. To explore the mechanism of the circFBXW7, RNA pull-down assay, dual luciferase reporter assay, and RNA immunoprecipitation (RIP) assay were employed to examine the interaction between circFBXW7 and miR-942-5p. Western blot was used to study the fundamental proteins associated with the epithelial-mesenchymal transition (EMT) pathway. In vivo studies with BALB/c nude mice subcutaneously injected with cells stably overexpressing circFBXW7 were performed to further validate the in vitro results. RESULTS: circFBXW7 was downregulated in LUAD cell lines and tissues, and LUAD patients with lower levels had shorter DFS and OS. The in vitro study showed that circFBXW7 overexpression inhibited proliferation and migration of A549 and HCC2279 cell lines. These results were confirmed by circFBXW7 knockdown, which showed the reverse effect. The in vivo model showed that the circRNA levels influenced the tumor growth. Finally, we determined that circFBXW7 target miRNA-942-5p which regulates the EMT gene BARX2. The modulation of circFBXW7 levels produced significant changes in EMT genes in vitro and in vivo. CONCLUSIONS: Our findings showed that circFBXW7 inhibits proliferation and migration by controlling the miR-942-5p/BARX2 axis in LUAD cell lines and its levels correlates with patient survival suggesting that regulating circFBXW7 could have therapeutic value in treating LUAD patients. |
format | Online Article Text |
id | pubmed-8044477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-80444772021-04-21 circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p Dong, Yanting Qiu, Tong Xuan, Yunpeng Liu, Ao Sun, Xiao Huang, Zhangfeng Su, Wenhao Du, Wenxing Yun, Tianxiang Wo, Yang Navarro, Alfons Jiao, Wenjie Transl Lung Cancer Res Original Article BACKGROUND: As a type of non-coding RNA, circular RNAs (circRNAs) are considered to be functional molecules associated with human cancers. An increasing number of circRNAs have been verified in malignant progression in a number of cancers. The circRNA, circFBXW7, has been proven to play an important role in tumor proliferation and metastasis. However, whether circFBXW7 influences progression in lung adenocarcinoma (LUAD) remains unclear. METHODS: Quantitative real-time reverse transcriptase PCR (qRT-PCR) was used to verify circFBXW7 in LUAD cell lines and LUAD tissues. Kaplan-Meier analysis was then used to compare the disease-free survival (DFS) and overall survival (OS) of these LUAD patients. The biological function of circFBXW7 was examined by overexpression and knockdown of circFBXW7 using MTT assay, EdU assay, wound-healing assay, and Transwell in vitro assays. To explore the mechanism of the circFBXW7, RNA pull-down assay, dual luciferase reporter assay, and RNA immunoprecipitation (RIP) assay were employed to examine the interaction between circFBXW7 and miR-942-5p. Western blot was used to study the fundamental proteins associated with the epithelial-mesenchymal transition (EMT) pathway. In vivo studies with BALB/c nude mice subcutaneously injected with cells stably overexpressing circFBXW7 were performed to further validate the in vitro results. RESULTS: circFBXW7 was downregulated in LUAD cell lines and tissues, and LUAD patients with lower levels had shorter DFS and OS. The in vitro study showed that circFBXW7 overexpression inhibited proliferation and migration of A549 and HCC2279 cell lines. These results were confirmed by circFBXW7 knockdown, which showed the reverse effect. The in vivo model showed that the circRNA levels influenced the tumor growth. Finally, we determined that circFBXW7 target miRNA-942-5p which regulates the EMT gene BARX2. The modulation of circFBXW7 levels produced significant changes in EMT genes in vitro and in vivo. CONCLUSIONS: Our findings showed that circFBXW7 inhibits proliferation and migration by controlling the miR-942-5p/BARX2 axis in LUAD cell lines and its levels correlates with patient survival suggesting that regulating circFBXW7 could have therapeutic value in treating LUAD patients. AME Publishing Company 2021-03 /pmc/articles/PMC8044477/ /pubmed/33889522 http://dx.doi.org/10.21037/tlcr-21-230 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Dong, Yanting Qiu, Tong Xuan, Yunpeng Liu, Ao Sun, Xiao Huang, Zhangfeng Su, Wenhao Du, Wenxing Yun, Tianxiang Wo, Yang Navarro, Alfons Jiao, Wenjie circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title | circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title_full | circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title_fullStr | circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title_full_unstemmed | circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title_short | circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p |
title_sort | circfbxw7 attenuates malignant progression in lung adenocarcinoma by sponging mir-942-5p |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044477/ https://www.ncbi.nlm.nih.gov/pubmed/33889522 http://dx.doi.org/10.21037/tlcr-21-230 |
work_keys_str_mv | AT dongyanting circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT qiutong circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT xuanyunpeng circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT liuao circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT sunxiao circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT huangzhangfeng circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT suwenhao circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT duwenxing circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT yuntianxiang circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT woyang circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT navarroalfons circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p AT jiaowenjie circfbxw7attenuatesmalignantprogressioninlungadenocarcinomabyspongingmir9425p |